Le Lézard
Classified in: Health, Business
Subject: CXP

Perry Health Progresses in its Mission to Democratize Healthcare Accessibility with Expansion into Pennsylvania and Oklahoma


Enhanced Chronic Care Access Now Extended to Seniors in its 22nd and 23rd Market

PHILADELPHIA and OKLAHOMA CITY, Oct. 17, 2023 /PRNewswire/ -- Perry Health is excited to announce the expansion of its services to patients living in Pennsylvania and Oklahoma. Perry is a leader in breaking down barriers to chronic care access for seniors, and these new locations mark the company's 22nd and 23rd markets. Perry's continued growth into new markets reinforces the company's commitment to providing accessible care and closing gaps for patients nationwide.

Perry Health is grounded in the belief that quality healthcare should be available to all, regardless of location, economic status, or other challenges. By merging advanced technology with expert medical advice, the company ensures that patients receive the personalized care they need, when they need it.

A cornerstone of Perry Health's service is providing every patient with its connected blood glucose meter, which is integrated with the company's overall care approach. In addition to receiving a device and unlimited testing supplies, every patient has 24/7 access to a dedicated team of healthcare providers who create customized care plans and provide the support our patients need to improve their health.

Perry Health enables its members to manage their diabetes effectively and ultimately achieve notable reductions in A1c blood sugar levels. The program aims to ensure patients receive consistent care in between their visits to primary care providers and other specialists. Eliminating these gaps and offering ongoing support not only enhances patient outcomes but also helps to ease the burden on the healthcare system.

Perry Health is particularly committed to serving underserved populations, playing a vital role in ensuring that everyone, regardless of their situation, has access to top-tier diabetes management solutions.

"The expansion into Pennsylvania and Oklahoma underscores our ongoing commitment to broaden our reach and deliver comprehensive healthcare services to more people across the country," said Pan Chaudhury, Co-founder and CEO of Perry Health. "Especially as we navigate the complexities of providing care to senior communities, our mission is to empower individuals to manage their health effectively, enhancing their quality of life."

Perry Health's venture into these new markets highlights its ongoing dedication to transforming diabetes care and fostering a healthier future for all.

For media inquiries, please contact:

Margot Daiber
(855) 525-1350
[email protected]

About Perry Health:

Perry Health is a pioneering healthcare company that reimagines diabetes care by providing a connected blood glucose meter, unlimited supplies, and personalized coaching led by medical experts. With the mission to make healthcare accessible to all, regardless of location or socioeconomic status, Perry Health empowers patients to manage their diabetes effectively and reduce A1c blood sugar levels. The company is based in New York and is led by Co-founders Pan Chaudhury and Scott Chesrown. Investors include Left Lane Capital, Primary Ventures, General Catalyst, Lerer Hippeau, StepStone Group among others. To learn more, visit perryhealth.com.

SOURCE Perry Health


These press releases may also interest you

at 05:09
Medical imaging IT and cybersecurity company Sectra (STO: SECT B) is publishing its Annual Report and Sustainability Report for the 2023/2024 fiscal year today. This report also includes the Corporate Governance Report for the same period. The...

at 03:20
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...

at 03:00
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...

at 02:30
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...



News published on and distributed by: